Similar articles

• [Molecular lesion and pathophysiology of hyperglycinemia: glycine cleavage system, physiology and pathology].

  Tada K. Tada K. Seikagaku. 1993 Apr;65(4):248-59. Seikagaku. 1993. PMID: 8315308 Review. Japanese. No abstract available.
• [Nonketotic hyperglycinemia].

  Tada K, Kure S. Tada K, et al. Ryoikibetsu Shokogun Shirizu. 1998;(18 Pt 1):227-30. Ryoikibetsu Shokogun Shirizu. 1998. PMID: 9590032 Review. Japanese. No abstract available.
• Concerns regarding transience and heterozygosity in neonatal hyperglycenemia.

  Hamosh A, Van Hove J. Hamosh A, et al. Ann Neurol. 2003 May;53(5):685; author reply 685-6. doi: 10.1002/ana.10532. Ann Neurol. 2003. PMID: 12731008 No abstract available.
• Molecular prenatal diagnosis of non-ketotic hyperglycinemia (glycine encephalopathy).

  Applegarth DA, Rolland MO, Toone JR, Coulter-Mackie M, Saura R. Applegarth DA, et al. Prenat Diagn. 2002 Mar;22(3):266-7. doi: 10.1002/pd.293. Prenat Diagn. 2002. PMID: 11920907 No abstract available.
• Model mice for mild-form glycine encephalopathy: behavioral and biochemical characterizations and efficacy of antagonists for the glycine binding site of N-methyl D-aspartate receptor.

  Kojima-ishii K, Kure S, Ichinohe A, Shinka T, Narisawa A, Komatsuzaki S, Kanno J, Kamada F, Aoki Y, Yokoyama H, Oda M, Sugawara T, Mizoi K, Nakahara D, Matsubara Y. Kojima-ishii K, et al. Pediatr Res. 2008 Sep;64(3):228-33. doi: 10.1203/PDR.0b013e3181799562. Pediatr Res. 2008. PMID: 18414141